These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 13221464)

  • 1. NEW AND nonofficial remedies: cycrimine hydrochloride.
    J Am Med Assoc; 1955 Feb; 157(6):510-1. PubMed ID: 13221464
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of a new agent in the treatment of parkinsonism.
    MULDER DW
    Proc Staff Meet Mayo Clin; 1953 Apr; 28(7):210-6. PubMed ID: 13056003
    [No Abstract]   [Full Text] [Related]  

  • 3. The treatment of parkinsonism with a new antispasmodic compound.
    MAGEE KR; DEJONG RN
    Med Bull (Ann Arbor); 1953 Mar; 19(3):59-61. PubMed ID: 13049719
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical evaluation of pagitane hydrochloride in parkinsonism.
    DOW RS; SMITH GN
    Neurology; 1954 Jan; 4(1):33-9. PubMed ID: 13133049
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of parkinsonism with pagitane hydrochloride; results in 142 patients.
    ZIER A; DOSHAY LJ
    Neurology; 1954 Sep; 4(9):682-9. PubMed ID: 13214268
    [No Abstract]   [Full Text] [Related]  

  • 6. [An observation on the treatment of Parkinson's syndrome; results with the new drug ParKS 12].
    HARDER A; PRELICZ T
    Schweiz Med Wochenschr; 1956 Mar; 86(13):335-8. PubMed ID: 13337189
    [No Abstract]   [Full Text] [Related]  

  • 7. Ethopropazine (parsidol) hydrochloride in treatment of paralysis agitans; posology, method of administration, and effects.
    DOSHAY LJ; CONSTABLE K; AGATE FJ
    J Am Med Assoc; 1956 Feb; 160(5):348-51. PubMed ID: 13278201
    [No Abstract]   [Full Text] [Related]  

  • 8. Quantitative measurement of therapy in paralysis agitans.
    AGATE FJ; DOSHAY LJ; CURTIS FK
    J Am Med Assoc; 1956 Feb; 160(5):352-4. PubMed ID: 13278202
    [No Abstract]   [Full Text] [Related]  

  • 9. The action of 267C (1-(1-piperidyl)-6-methyl-3-phenyl-3-heptanol hydrochloride) in Parkinson's disease.
    GIANVITO L; JACKSON I; MCGAVACK TH
    J Am Geriatr Soc; 1956 Aug; 4(8):793-6. PubMed ID: 13357272
    [No Abstract]   [Full Text] [Related]  

  • 10. Antispasmodic compound 08958 in treatment of paralysis agitans.
    MAGEE KR; DEJONG RN
    J Am Med Assoc; 1953 Oct; 153(8):715-8. PubMed ID: 13096281
    [No Abstract]   [Full Text] [Related]  

  • 11. Five-year study of benztropine (cogentin) methanesulfonate; outcome in three hundred two cases of paralysis agitans.
    DOSHAY LJ
    J Am Med Assoc; 1956 Nov; 162(11):1031-4. PubMed ID: 13366700
    [No Abstract]   [Full Text] [Related]  

  • 12. [Parkinzan therapy of patients with parkinsonism].
    LITVAK LB; FILATOVA AD
    Sov Med; 1960 Feb; 24():126-9. PubMed ID: 14417566
    [No Abstract]   [Full Text] [Related]  

  • 13. Trial of a new remedy (Ciba 10870) in Parkinsonism.
    HUGHES W; KEEVIL JH; GIBBS IE
    Br Med J; 1958 Apr; 1(5076):928-9. PubMed ID: 13523232
    [No Abstract]   [Full Text] [Related]  

  • 14. Kemadrin in postencephalitic parkinsonism.
    MONTUSCHI E; PHILLIPS J; PRESCOTT F; GREEN AF
    Lancet; 1952 Mar; 1(6708):583-5. PubMed ID: 14909471
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of Parkinsonism.
    GILLHESPY RO; BALESTRIERI A; SIGNORATO U
    Br Med J; 1958 Jun; 1(5086):1542. PubMed ID: 13546622
    [No Abstract]   [Full Text] [Related]  

  • 16. Parsidol in the treatment of Parkinson's syndrome.
    SOBUE I; IVES ER
    Bull Los Angel Neuro Soc; 1956 Jun; 21(2):80-3. PubMed ID: 13329559
    [No Abstract]   [Full Text] [Related]  

  • 17. The treatment of the Parkinson's syndrome with special reference to the value of aturbane.
    GILLHESPY RO
    Br J Clin Pract; 1960 Apr; 14():287-90. PubMed ID: 13850112
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of benzotropine sulfonate in the treatment of parkinsonism.
    O'DOHERTY D; FORSTER FM
    Med Ann Dist Columbia; 1953 May; 22(5):221-3. PubMed ID: 13045920
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic activity of a new drug, M.G. 1229, 4-(gamma-diethylaminopropyl)-hydroxydiphenylethane, in the parkinsonian syndrome].
    DONATI A; MORI G
    Gazz Med Ital; 1956 Oct; 115(10):331-4. PubMed ID: 13384655
    [No Abstract]   [Full Text] [Related]  

  • 20. [Activity of kemadrin on the symptoms of Parkinson's disease; comparison with other therapeutics].
    SIGWALD J
    Presse Med (1893); 1953 Jan; 61(7):127-8. PubMed ID: 13055735
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.